Erenumab vs Methotrexate

Erenumab vs Methotrexate: Overview

This comparison examines the pharmacological differences between Erenumab and Methotrexate.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5.

Molecular Weight: Methotrexate — 454.4400 g/mol.

Type: Erenumab — Antibody; Methotrexate — Small molecule.